Association of mindfulness with female sexual dysfunction
- PMID: 35688491
- PMCID: PMC11309572
- DOI: 10.1016/j.maturitas.2022.02.002
Association of mindfulness with female sexual dysfunction
Abstract
Objectives: Female sexual dysfunction (FSD) affects women of all ages. It is often a multifactorial problem with a strong psychosocial component. Mindfulness may help alleviate FSD with nonjudgmental, present-moment awareness and decreased emotional reactivity. The goal of this study was to assess the association between dispositional or trait mindfulness and FSD.
Study design: In this cross-sectional study at a tertiary care women's health clinic, 1718 cisgender women (mean age, 51.9 years) completed the Mindfulness Attention Awareness Scale (MAAS), Female Sexual Function Index (FSFI), and Female Sexual Distress Scale-Revised (FSDS-R).
Main outcome measures: Regression analysis was used to test the associations of mindfulness, sexual function, and sexual distress with univariate and multivariable analyses, adjusting for potential confounders.
Results: Within the sample, 57% of women met FSD criteria (FSFI scores ≤26.55 and FSDS-R ≥ 11). On univariate analysis, higher MAAS scores, signifying greater mindfulness, were associated with higher (better) sexual function scores, lower sexual distress scores, and lower odds of FSD. This association persisted on multivariable analysis after adjusting for potential confounders.
Conclusions: Higher trait mindfulness was associated with better sexual function, lower sexual distress, and lower likelihood of FSD. Further studies are needed to assess the role of mindfulness in mitigating FSD.
Keywords: Dispositional mindfulness; Female sexual dysfunction; Mindfulness; Sexual distress; Trait mindfulness.
Copyright © 2022. Published by Elsevier B.V.
Conflict of interest statement
Richa Sood's husband is the owner/CEO of Global Center for Resiliency and Well-being and The GRIT Institute. Ekta Kapoor has received consultant fees for Astellas Pharmaceuticals, personal fees from CogniMed, personal fees from Med Learning Group, consultant fees and grant support from Mithra Pharmaceuticals, personal fees from PriMed, and consultant fees from Womaness, all of which are outside the scope of the submitted work. All other authors declare that they have no competing interests.
Figures
Comment in
-
Male and Female Sexual Function and Dysfunction; Andrology.J Urol. 2023 Jan;209(1):282-284. doi: 10.1097/JU.0000000000003019. Epub 2022 Oct 12. J Urol. 2023. PMID: 36250934 No abstract available.
References
-
- World Health Organization, Measuring Sexual health: Conceptual and Practical Considerations and Related Indicators, World Health Organization, Geneva, Switzerland, 2010, p. 22.
-
- Clayton AH, Valladares Juarez EM, Female Sexual Dysfunction, Med. Clin. North Am 103 (4) (2019) 681–698. - PubMed
-
- McCabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E, Lee SW, Lewis R, Segraves RT, Definitions of sexual dysfunctions in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015, J. Sex. Med 13 (2) (2016) 135–143. - PubMed
-
- Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB, Sexual problems and distress in United States women: prevalence and correlates, Obstet. Gynecol 112 (5) (2008) 970–978. - PubMed
-
- McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, Laumann E, Lee SW, Segraves RT, Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015, J. Sex. Med 13 (2) (2016) 144–152. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
